Senti Bio believes it can outsmart complex diseases and transform the future of medicine.

At Senti, our vision is to become an industry leader in the cell and gene therapy landscape. We are pursuing this goal by advancing our gene circuit platform to discover, develop, manufacture and globally commercialize new classes of cell and gene therapies across therapeutic areas and modalities.

Partnerships are important to this vision, enabling us to potentially explore the promise of gene circuits more broadly with partners who have complementary capabilities and know-how.

Engineering smarter medicines by programming cells with gene circuits

We view gene circuits as a potential component of advanced cell and gene therapies. Gene circuits may enable us to address indications that conventional small molecule, protein and cell and gene therapies cannot.

In the area of Oncology, Senti is advancing its own portfolio of NK cell product candidates. In other therapeutic areas, such as immunology, neuroscience, genetic disease, cardiovascular disease and regenerative medicine, Senti plans to maximize the commercial potential of our gene circuit platform technologies via strategic collaborations.